{"id":11413,"date":"2018-06-12T13:19:11","date_gmt":"2018-06-12T11:19:11","guid":{"rendered":"https:\/\/www.mannheimerswartling.se\/?p=11413"},"modified":"2021-03-11T16:53:01","modified_gmt":"2021-03-11T15:53:01","slug":"nordic-capital-avyttrar-anicura-till-mars-petcare","status":"publish","type":"post","link":"https:\/\/www.mannheimerswartling.se\/uppdrag\/nordic-capital-avyttrar-anicura-till-mars-petcare\/","title":{"rendered":"Nordic Capital avyttrar AniCura till Mars Petcare"},"content":{"rendered":"<p>Nordic Capital VIII har ing\u00e5tt avtal om att avyttra AniCura till Mars Petcare. AniCura \u00e4r en av Europas ledande leverant\u00f6rer av avancerad djursjukv\u00e5rd f\u00f6r s\u00e4llskapsdjur. Aff\u00e4ren \u00e4r villkorad av sedvanliga regulatoriska godk\u00e4nnanden och parterna har kommit \u00f6verens om att inte avsl\u00f6ja de finansiella detaljerna f\u00f6r aff\u00e4ren.<\/p>\n<p>Sedan Nordic Capital blev majoritets\u00e4gare i AniCura under 2014 har bolaget vuxit fyrfaldigt och tillsammans med bolagets ledning har Nordic Capital omformat den europeiska marknaden genom skapandet av h\u00f6gkvalitativa specialiserade kliniker f\u00f6r djursjukv\u00e5rd. Under Nordic Capitals \u00e4gande har AniCura ut\u00f6kat antalet kliniker fr\u00e5n 50 till 200, antalet anst\u00e4llda fr\u00e5n 1 000 till 4 000 och pro forma-oms\u00e4ttningen har vuxit fr\u00e5n 900 miljoner kronor till 3.3 miljarder kronor.<\/p>\n<p>Nordic Capital f\u00f6retr\u00e4ds av Mannheimer Swartling i transaktionen.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nordic Capital VIII har ing\u00e5tt avtal om att avyttra AniCura till Mars Petcare. AniCura \u00e4r en av Europas ledande leverant\u00f6rer av avancerad djursjukv\u00e5rd f\u00f6r s\u00e4llskapsdjur.\u2026<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3469],"tags":[],"class_list":["post-11413","post","type-post","status-publish","format-standard","hentry","category-uppdrag","business-group-eu-och-konkurrensratt","business-group-fonder-och-investeringar","business-group-foretagsoverlatelser","business-group-private-equity"],"acf":[],"lang":"sv","translations":{"sv":11413,"en":11415},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/11413"}],"collection":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/comments?post=11413"}],"version-history":[{"count":2,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/11413\/revisions"}],"predecessor-version":[{"id":14725,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/11413\/revisions\/14725"}],"wp:attachment":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media?parent=11413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/categories?post=11413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/tags?post=11413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}